Loading...
Please wait, while we are loading the content...
Emerging immunotherapies for rheumatoid arthritis
| Content Provider | Scilit |
|---|---|
| Author | Reynolds, Gary Cooles, Faye A. H. Isaacs, John Hilkens, Catharien M. U. |
| Copyright Year | 2014 |
| Description | Journal: Human vaccines & immunotherapeutics Novel treatments in development for rheumatoid arthritis target 3 broad areas: cytokines, cells, and signaling pathways. Therapies from each domain share common advantages (for example previously demonstrated efficacy, potential long-term immunomodulation, and oral administration respectively) that have stimulated research in each area but also common obstacles to their development. In this review recent progress in each area will be discussed alongside the factors that have impeded their path to clinical use. |
| Related Links | https://www.tandfonline.com/doi/pdf/10.4161/hv.27910?needAccess=true https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896612/pdf |
| Ending Page | 837 |
| Page Count | 16 |
| Starting Page | 822 |
| ISSN | 21645515 |
| e-ISSN | 2164554X |
| DOI | 10.4161/hv.27910 |
| Journal | Human vaccines & immunotherapeutics |
| Issue Number | 4 |
| Volume Number | 10 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2014-04-28 |
| Access Restriction | Open |
| Subject Keyword | Journal: Human vaccines & immunotherapeutics Rheumatology Anti-chemokine Therapy Anti-cytokine Therapy Cellular Therapy Immunotherapy Rheumatoid Arthritis Small Molecule Inhibitors |
| Content Type | Text |
| Subject | Immunology and Allergy Immunology Pharmacology |